RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity ...Middle East

Series B financing led by CBC with participation from Temasek's Pavilion Capital, EDBI and GS Holdings RVAC plans to build R&D center and manufacturing facilities in Singapore and China SINGAPORE, April 26, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. ("RVAC"), an emerging messenger RNA...

Hence then, the article about rvac medicines a cbc incubated mrna platform company raises us 140 million to expand r d and manufacturing capacity was published today ( Wednesday 27/04/2022 - 05:14 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity )

Also on site :

• UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
• Scott Ritter say he was ‘de-banked’
• AI boom fuels fears of an industry bubble (VIDEO)